PIC
PROF

PCJ Investment Counsel’s Profound Medical PROF Stock Holding History

PCJ Investment Counsel’s Portfolio PROF Stock Details PROF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-110,999
Closed -$811K – 80
2022
Q2 		$811K Hold
110,999
– – 0.4% 62
2022
Q1 		$998K Sell
110,999
-401
-0.4% -$3.86K 0.36% 63
2021
Q4 		$1.26M Sell
111,400
-27,070
-20% -$338K 0.44% 56
2021
Q3 		$2.02M Sell
138,470
-26,750
-16% -$407K 0.73% 48
2021
Q2 		$2.69M Buy
165,220
+19,990
+14% +$372K 1.01% 35
2021
Q1 		$2.91M Buy
145,230
+18,300
+14% +$439K 1.15% 31
2020
Q4 		$2.61M Buy
126,930
+5,370
+4% +$98.8K 1.22% 31
2020
Q3 		$2.14M Buy
121,560
+29,440
+32% +$468K 0.97% 34
2020
Q2 		$1.56M Sell
92,120
-2,300
-2% -$29K 0.76% 42
2020
Q1 		$909K Buy
+94,420
New +$1.22M 0.63% 39

Other funds holding PROF

GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
LBA
Letko, Brosseau & Associates Montreal, Quebec, Canada $6.2B AUM 38.92% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
GA
Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $127M AUM 23.73% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
ZDA
Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return

PCJ Investment Counsel's PROF Position: Q3 2022 in Review

PCJ Investment Counsel sold out of Profound Medical (PROF) in Q3 2022, closing a stake of 110,999 shares — an estimated $811K sold.

PCJ Investment Counsel first reported a position in PROF in Q1 2020 and held it in 10 quarters. The position peaked at $2.91M in Q1 2021. 35 funds tracked by Wall St. Rank hold PROF as of Q3 2022.

  • PCJ Investment Counsel reported no remaining Profound Medical position as of Q3 2022 after selling out during the quarter.
  • PCJ Investment Counsel sold 110,999 Profound Medical shares in Q3 2022, an estimated $811K.
  • PCJ Investment Counsel first reported a position in Profound Medical in Q1 2020 and held it in 10 quarters.
  • PCJ Investment Counsel's Profound Medical position peaked at $2.91M in Q1 2021.
  • 35 funds tracked by Wall St. Rank held Profound Medical as of Q3 2022.

Based on PCJ Investment Counsel's 13F filing for Q3 2022, filed 10 Nov 2022.